- Home
- WKHS vs TPST Comparison
WKHS vs TPST Comparison
Compare WKHS & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKHS | TPST |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 15.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WKHS | TPST |
|---|---|---|
| Price | $5.37 | $2.90 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $21.00 | $12.50 |
| AVG Volume (30 Days) | ★ 374.0K | 109.2K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,620,296.00 | N/A |
| Revenue This Year | $92.70 | N/A |
| Revenue Next Year | $34.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.73 | N/A |
| 52 Week Low | $5.10 | $2.87 |
| 52 Week High | $139.70 | $13.65 |
Technical Indicators
Market Signals| Indicator | WKHS | TPST |
|---|---|---|
| Relative Strength Index (RSI) | 64.55 | 26.67 |
| Support Level | $5.20 | $2.87 |
| Resistance Level | $5.68 | $3.20 |
| Average True Range (ATR) | 0.57 | 0.14 |
| MACD | -0.11 | 0.23 |
| Stochastic Oscillator | 13.70 | 12.50 |
Price Performance
Historical ComparisonAbout WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.